Our Company
Phylos is a cannabis genetics company that empowers growers of all sizes to produce the highest-quality cannabis in the most cost-effective way.
Phylos is a cannabis genetics company that empowers growers of all sizes to produce the highest-quality cannabis in the most cost-effective way. Phylos supports commercial-scale cultivation with the industry’s first Production-Ready Seed™: premium, phenotypically stable, fully-feminized F1 hybrid seed lines that deliver exceptional flower quality, potency, vigor, and yield. Phylos also leverages its proprietary, patent-pending technology to provide partners with unparalleled rare cannabinoid genetics. It creates natural, safe, and effective ingredients under its Natural Natural brand utilizing its cultivation, extraction, and formulation expertise. Natural Natural’s THCV varieties power a high-quality supply chain of naturally-derived THCV.
Find us in the news. Explore our job opportunities.
Genetics for a Growing Industry
Our team of geneticists, breeders, plant scientists, and agronomists use a data-driven approach to crop and production improvement. Using genetic markers, our team selects plants with naturally occurring traits for our breeding program. This enables us to develop varieties more quickly that provide more seed variety choices and profitable, sustainable solutions to growers who need consistency and reliability.
Take a look at our seed varieties.
Natural Rare Cannabinoids
We started Natural Natural to provide the industry with safe access to rare cannabinoids. Starting with the world's first 20% THCV plant, Get Sh*t Done, we’ve partnered along the supply chain in 10 markets with more coming online in 2024. We believe cannabinoids should be sourced naturally, from plants grown by farmers. Not grown or created synthetically in a lab. Natural cannabinoid products, like Natural Natural THCV, are made from phytocannabinoids created by an enzyme inside the plant, so 100% of the time you get the same molecules and there is no uncertainty.
Learn more about Natural Natural.
Innovation Partnerships
Phylos’ Innovation Partner program builds strategic partnerships with cannabis operators around the globe. Combining genetics developed by Phylos’ modern scientific breeding program with partner core competencies creates a competitive advantage through product innovation and seed-based production.
Read about our latest addition to the Innovation Partner Program.
Quality-First Seed Control
Our expert breeders, high-quality uniform seed lines, and rigorous quality control measures put grower success first, ultimately increasing harvest yield and profitability for growers of any size. Phylos seeds produce stable, cannabinoid-rich female plants and are backed by rigorous analyses that include chemical, feminization, germination, genetic purity, and genetic testing for chain of custody.
Variety Licensing
We work with breeders to in-license unique genetics for continued development and optimization to bring their seeds or clones to market. Our partners choose to work with Phylos to take advantage of our rigorous infrastructure, quality control systems, sales, marketing, agronomic support teams, and our licensing agreements which provide fair compensation for their years of hard work.
Field-Based Grower Support
Our sales and field teams bring the best practices from traditional agriculture and cannabis cultivation to support growers with the tools and resources for success. We work with farms around the country and around the world to conduct field trials to assess our seeds at scale and identify climate-specific traits. Since 2020, we have performed seed trials at 35+ different locations.
The power of cannabis and hemp drives everything we do
Our mission is to unlock the potential of the cannabis plant, improving grower prosperity and enhancing consumer well-being.
Since 2014, we’ve worked to build the infrastructure necessary to support growers’ success in cannabis. Take a stroll through our history that brought us here today.
Elite F1 Hybrid Seeds
Released Elite Seed Varieties that can compete with indoor clonal cultivars. For the first time, seeds are producing top shelf flower quality, higher potency; rich, unique aroma profiles; and stress tolerance for indoor grows.
Natural Natural THCV
Partnered throughout the supply chain to launch Phylos Natural Natural THCV–naturally-occurring high-potency THCV–in branded products across Canada and 6 U.S. states. Releasing the first THCV-dominant strains with proven efficacy for energizing effects without the munchies.
Improved F1 hybrid seeds + rare cannabinoids
Released improved F1 hybrid hemp and THC seed lines (short- and full-season), as well as rare cannabinoid dominant cultivars. Key product attributes of new lines include high cannabinoid content, diverse terpene profiles, yield, vigor and early maturity.
Production-Ready F1 Hybrid Seeds
Released first uniform, day-neutral, short season, high THC, F1 hybrid seed lines. Exceptional 75 days from seed to maturity, requiring no supplemental light.
AutoCBD F1 Hybrid Hemp Seeds
Released flagship autoflower hemp seed. Extensive germplasm evaluations, trials, and breeding advancements across product platforms.
R&D Breeding Facility
Launched an 80,000 ft2 state of the art glasshouse R&D facility with contracted breeder-partners for plant analysis and breeding. The first-of-its-kind licensed for both cannabis and hemp.
Breeding Partnerships
Launched collaborative studies with breeding partners to identify new cannabis varieties with improved traits.
Partnership with Illumina
Partnered with the world’s leading sequencing company, developing the first cannabis genotyping array and generating 50,000 unique data points for each plant to enable rapid genetic gain.
Genotype Test
Launched genomic testing product that validates cannabis and hemp strains for growers and breeders, clarifying and illuminating the cannabis supply chain.
Published Genomic Data
The foundational knowledge of the cannabis genome can be advanced and better understood by sharing the data we collected for the Galaxy. In 2016, we made initial genetic sequencing data available publicly via the National Center for Biotechnology Information. (Learn more about viewing open data in the NCBI database.)
To download all public Phylos-collected genotype data, visit EBI’s archive.
Reference Genome
Assembled and shared a complete cannabis reference genome from worldwide samples.
The Phylos Galaxy
Created the world’s largest 3D visualization and benchmarking tool of industrial hemp and cannabis DNA. The Phylos Galaxy features thousands of varietal hemp and cannabis DNA samples from over 80 countries. It's the most advanced population visualization in existence. Mapped to 6 different sub-populations, the Galaxy showcases the diversity of hemp and cannabis samples through 3D data visualization and genetic reports.
Cannabis Evolution Project
Analyzed the DNA of thousands of cannabis samples from around the world.
The Plant Sex Test
Launched genomic testing product that helps growers and breeders cull males from growing populations, driving operational efficiency and lowering cost of doing business.